SB 212

Kansas Senate bill in Session 2025-2026.

Status: failed. Latest action: April 10, 2026.

SB212 - Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Bill ID KS-2025-2026-SB-212
Session 2025-2026
Status failed
Committee Financial Institutions and Insurance
Senate failed 2026-04-10
Summary

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Sponsor
Sen. Dinah Sykes
Official Source Back to Bills
Actions Timeline
Date Event Detail
2025-02-05 Introduced Bill introduced
2026-04-10 Status failed
2026-04-10 Latest Action Died in Committee
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States